Bandelow B., Michaelis S. Epidemiology of Anxiety Disorders in the 21st Century. Clin Neurosci. 2022;(17):327–335. https://doi.org/10.31887/DCNS.2015.17.3/bbandelow..
DOI: 10.31887/DCNS.2015.17.3/bbandelow
McKnight P.E., Monfort S.S., Kashdan T.B., Blalock D.V., Calton J.M. Anxiety Symptoms and Functional Impairment: A Systematic Review of the Correlation between the Two Measures. Clin Psychol Rev. 2016;(45):115–130. https://doi.org/10.1016/j.cpr.2015.10.005..
DOI: 10.1016/j.cpr.2015.10.005
Love A.S., Love R. Anxiety Disorders in Primary Care Settings. Nurs Clin North Am. 2019;54(4):473–493. https://doi.org/10.1016/j.cnur.2019.07.002..
DOI: 10.1016/j.cnur.2019.07.002
Manjunatha N., Ram D. Panic Disorder in General Medical Practice A Narrative Review. J Family Med Prim Care. 2022;11(3):861–869. https://doi.org/10.4103/jfmpc.jfmpc_888_21..
DOI: 10.4103/jfmpc.jfmpc_888_21
Alonso J., Buron A., Bruffaerts R., He Y., Posada-Villa J., Lepine J.P. et al. Association of Perceived Stigma and Mood and Anxiety Disorders: Results from the World Mental Health Surveys. Acta Psychiatr Scand. 2008;118(4):305–314. https://doi.org/10.1111/j.1600-0447.2008.01241.x..
DOI: 10.1111/j.1600-0447.2008.01241.x
Goldstein-Piekarski A.N., Williams L.M., Humphreys K. A Trans-Diagnostic Review of Anxiety Disorder Comorbidity and the Impact of Multiple Exclusion Criteria on Studying Clinical Outcomes in Anxiety Disorders. Transl Psychiatry. 2016;6(6):e847. https://doi.org/10.1038/tp.2016.108..
DOI: 10.1038/tp.2016.108
Saeed H., Eslami A., Nassif N.T., Simpson A.M., Lal S. Anxiety Linked to COVID-19: A Systematic Review Comparing Anxiety Rates in Different Populations. Int J Environ Res Public Health. 2022;19(4):2189. https://doi.org/10.3390/ijerph19042189..
DOI: 10.3390/ijerph19042189
Craske M.G. Anxiety Disorders: Psychological Approaches to Theory and Treatment. Boulder, CO: Westview Press; 1999. 425 p. Available at: https://psycnet.apa.org/record/1998-06744-000.https://psycnet.apa.org/record/1998-06744-000
Craske M.G. Anxiety Disorders: Psychological Approaches to Theory and Treatment. Boulder, CO: Westview Press; 1999. 425 p. Available at: https://psycnet.apa.org/record/1998-06744-000.https://psycnet.apa.org/record/1998-06744-000
Willson M. DSM-III and the Transformation of American Psychiatry: A History. Am J Psychiatry. 1993;150(3):399–410. https://doi.org/10.1176/ajp.150.3.399..
DOI: 10.1176/ajp.150.3.399
The diagnosis and treatment of peripheral lymphedema: 2020 Consensus Document of the International Society of Lymphology. Lymphology. 2020;53(1):3–19. https://pubmed.ncbi.nlm.nih.gov/32521126/.https://pubmed.ncbi.nlm.nih.gov/32521126/
The diagnosis and treatment of peripheral lymphedema: 2020 Consensus Document of the International Society of Lymphology. Lymphology. 2020;53(1):3–19. https://pubmed.ncbi.nlm.nih.gov/32521126/.https://pubmed.ncbi.nlm.nih.gov/32521126/
Meier S.M., Deckert J. Genetics of Anxiety Disorders. Curr Psychiatry Rep. 2019;21(3):16. https://doi.org/10.1007/S11920-019-1002-7..
DOI: 10.1007/S11920-019-1002-7
Shimada-Sugimoto M., Otowa T., Miyagawa T., Umekage T., Kawamura Y., Bundo M. et al. Epigenome-Wide Association Study of DNA Methylation in Panic Disorder. Clin Epigenetics. 2017;9:1–11. https://doi.org/10.1186/S13148-016-0307-1..
DOI: 10.1186/S13148-016-0307-1
De Carvalho M.R., Dias G.P., Cosci F., De-Melo-Neto V.L., Bevilaqua M.C.D.N., Gardino P.F., Nardi A.E. Current Findings of FMRI in Panic Disorder: Contributions for the Fear Neurocircuitry and CBT Effects. Expert Rev Neurother. 2010;10(2):291–303. https://doi.org/10.1586/ern.09.161..
DOI: 10.1586/ern.09.161
Mochcovitch M.D., Da Rocha Freire R.C., Garcia R.F., Nardi A.E. A Systematic Review of FMRI Studies in Generalized Anxiety Disorder: Evaluating Its Neural and Cognitive Basis. J Affect Disord. 2014;(167):336–342. https://doi.org/10.1016/j.jad.2014.06.041..
DOI: 10.1016/j.jad.2014.06.041
Gruenberg A.M. Stahl’s Essential Psychopharmacology Neuroscientific Basis and Practical Application, Third Edition. By S. M. Stahl. Cambridge University Press: New York. 2008. Psychol Med. 2009;39(3):520–521. https://doi.org/10.1017/S0033291708005060..
DOI: 10.1017/S0033291708005060
Faravelli C., Sauro C.L., Lelli L., Pietrini F., Lazzeretti L., Godini L. et al. The Role of Life Events and HPA Axis in Anxiety Disorders: A Review. Curr Pharm Des. 2012;18(35): 5663–5674. https://doi.org/10.2174/138161212803530907..
DOI: 10.2174/138161212803530907
Kascakova N., Furstova J., Hasto J., Geckova A.M., Tavel P. The Unholy Trinity: Childhood Trauma, Adulthood Anxiety, and Long-Term Pain. Int J Environ Res Public Heal. 2020;17(2):414. https://doi.org/10.3390/ijerph17020414..
DOI: 10.3390/ijerph17020414
Mella N., Vallet F., Beaudoin M., Fagot D., Baeriswyl M., Ballhausen N. et al. Distinct Effects of Cognitive versus Somatic Anxiety on Cognitive Performance in Old Age: The Role of Working Memory Capacity. Aging Ment Health. 2020;24(4):604–610. https://doi.org/10.1080/13607863.2018.1548566..
DOI: 10.1080/13607863.2018.1548566
Волель Б.А., Петелин Д.С., Р.Д.В. Алгоритмы диагностики и терапии психических расстройств в общемедицинской практике. М.: МАИ; 2020. 78 с. Режим доступа: https://webmed.irkutsk.ru/doc/pdf/psmalgorythm.pdf.https://webmed.irkutsk.ru/doc/pdf/psmalgorythm.pdf
Волель Б.А., Петелин Д.С., Р.Д.В. Алгоритмы диагностики и терапии психических расстройств в общемедицинской практике. М.: МАИ; 2020. 78 с. Режим доступа: https://webmed.irkutsk.ru/doc/pdf/psmalgorythm.pdf.https://webmed.irkutsk.ru/doc/pdf/psmalgorythm.pdf
Davidson J., Feltner D.E., Dugar A. Management of Generalized Anxiety Disorder in Primary Care: Identifying the Challenges and Unmet Needs. Prim Care Companion J Clin Psychiatry. 2010;12(2):PCC.09r00772. https://doi.org/10.4088/PCC.09r00772blu..
DOI: 10.4088/PCC.09r00772blu
Gelenberg A.J. Psychiatric and Somatic Markers of Anxiety: Identification and Pharmacologic Treatment. Prim Care Companion J Clin Psychiatry 2000;2(2):49–54. https://doi.org/10.4088/pcc.v02n0204..
DOI: 10.4088/pcc.v02n0204
Yeo G.C., Hong R.Y., Riskind J.H. Looming Cognitive Style and Its Associations with Anxiety and Depression: A Meta-Analysis. Cognit Ther Res. 2020;(44):445–467. https://doi.org/10.1007/S10608-020-10089-1..
DOI: 10.1007/S10608-020-10089-1
Волель Б.А., Петелин Д.С., Ахапкин Р.В., Малютина А.А. Когнитивные нарушения при тревожных расстройствах. Неврология, нейропсихиатрия, психосоматика. 2018;10(1):78–82. https://doi.org/10.14412/2074-2711-2018-1-78-82..
DOI: 10.14412/2074-2711-2018-1-78-82
Carta M.G., Balestrieri M., Murru A., Hardoy M.C. Adjustment Disorder: Epidemiology, Diagnosis and Treatment. Clin Pract Epidemiol Ment Heal. 2009;(5):1–15. https://doi.org/10.1186/1745-0179-5-15..
DOI: 10.1186/1745-0179-5-15
Фомичева А.В., Андреев Д.А., Любавская А.А., Симонов А.Н., Волель Б.А. Клинико-психопатологические аспекты нозогенных реакций при хронической сердечной недостаточности. Журнал неврологии и психиатрии им. С.С. Корсакова. 2022;122(9):86–94. https://doi.org/10.17116/jnevro202212209186..
DOI: 10.17116/jnevro202212209186
Mahat-Shamir M., Pitcho-Prelorentzos S., Kagan M., Kestler-Peleg M., Lavenda O. Adjustment Disorder in the Face of COVID-19 Outbreak: The Impact of Death Anxiety, Media Exposure, Fear of Contagion and Hypochondriasis Symptoms. Omega. 2021;302228211034372. https://doi.org/10.1177/00302228211034372..
DOI: 10.1177/00302228211034372
Kendall T., Cape J., Chan M., Taylor C. Management of Generalised Anxiety Disorder in Adults: Summary of NICE Guidance. BMJ. 2011;(342):279–281. https://doi.org/10.1136/bmj.c7460..
DOI: 10.1136/bmj.c7460
Bandelow B., Allgulander C., Baldwin D.S., Costa D.L. da C., Denys D., Dilbaz N. et al. World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Treatment of Anxiety, Obsessive-Compulsive and Posttraumatic Stress Disorders–Version 3. Part I: Anxiety Disorders. World J Biol Psychiatry. 2023;24(2):79–117. https://doi.org/10.1080/15622975.2022.2086295..
DOI: 10.1080/15622975.2022.2086295
Strawn J.R., Mills J.A., Suresh V., Peris T.S., Walkup J.T., Croarkin P.E. Combining selective serotonin reuptake inhibitors and cognitive behavioral therapy in youth with depression and anxiety. J Affect Disord. 2022;298:292–300. https://doi.org/10.1016/j.jad.2021.10.047..
DOI: 10.1016/j.jad.2021.10.047
Otte C. Cognitive Behavioral Therapy in Anxiety Disorders: Current State of the Evidence. Dialogues Сlin Neurosci. 2011;13(4):413–421. https://doi.org/10.31887/DCNS.2011.13.4/cotte..
DOI: 10.31887/DCNS.2011.13.4/cotte
Hofmann S.G., Asnaani A., Vonk I.J.J., Sawyer A.T., Fang A. The Efficacy of Cognitive Behavioral Therapy: A Review of Meta-Analyses. Cognit Ther Res. 2012;36(5):427–440. https://doi.org/10.1007/S10608-012-9476-1..
DOI: 10.1007/S10608-012-9476-1
Murphy S.E., Capitão L.P., Giles S.L.C., Cowen P.J., Stringaris A., Harmer C.J. The Knowns and Unknowns of SSRI Treatment in Young People with Depression and Anxiety: Efficacy, Predictors, and Mechanisms of Action. Lancet Psychiatry. 2021;8(9):824–835. https://doi.org/10.1016/S2215-0366(21)00154-1..
DOI: 10.1016/S2215-0366(21)00154-1
Sansone R.A., Sansone L.A. SSRI-Induced Indifference. Psychiatry (Edgmont). 2010;7(10):14–18. Available at: https://pubmed.ncbi.nlm.nih.gov/21103140/.https://pubmed.ncbi.nlm.nih.gov/21103140/
Sansone R.A., Sansone L.A. SSRI-Induced Indifference. Psychiatry (Edgmont). 2010;7(10):14–18. Available at: https://pubmed.ncbi.nlm.nih.gov/21103140/.https://pubmed.ncbi
Jing E., Straw-Wilson K. Sexual Dysfunction in Selective Serotonin Reuptake Inhibitors (SSRIs) and Potential Solutions: A Narrative Literature Review. Ment Health Clin. 2016;6(4):191–196. https://doi.org/10.9740/mhc.2016.07.191..
DOI: 10.9740/mhc.2016.07.191
Petocz L. Pharmacologic Effects of Tofizopam (Grandaxin). Acta Pharm Hung. 1993;63(2):79–82. Available at: https://pubmed.ncbi.nlm.nih.gov/8100112/.https://pubmed.ncbi.nlm.nih.gov/8100112/
Petocz L. Pharmacologic Effects of Tofizopam (Grandaxin). Acta Pharm Hung. 1993;63(2):79–82. Available at: https://pubmed.ncbi.nlm.nih.gov/8100112/.https://pubmed.ncbi.nlm.nih.gov/8100112/
Bond A., Lader M. A Comparison of the Psychotropic Profiles of Tofisopam and Diazepam. Eur J Clin Pharmacol. 1982;22(2):137–142. https://doi.org/10.1007/BF00542458..
DOI: 10.1007/BF00542458
Klebovich I., Abermann M. Pharmacokinetics and Metabolism of Tofizopam (Grandaxin). Acta Pharm Hung. 1993;(63):83–90. Available at: https://pubmed.ncbi.nlm.nih.gov/8100113/.https://pubmed.ncbi.nlm.nih.gov/8100113/
Klebovich I., Abermann M. Pharmacokinetics and Metabolism of Tofizopam (Grandaxin). Acta Pharm Hung. 1993;(63):83–90. Available at: https://pubmed.ncbi.nlm.nih.gov/8100113/.https://pubmed.ncbi.nlm.nih.gov/8100113/
Eison A.S., Temple Jr. D.L. Buspirone: review of its pharmacology and current perspectives on its mechanism of action. Am J Med. 1986;80(3):1–9. https://doi.org/10.1016/0002-9343(86)90325-6..
DOI: 10.1016/0002-9343(86)90325-6
Loane C., Politis M. Buspirone: What Is It All About? Brain Res. 2012;1461:111–118. https://doi.org/10.1016/j.brainres.2012.04.032..
DOI: 10.1016/j.brainres.2012.04.032
Tunnicliff G. Molecular Basis of Buspirone’s Anxiolytic Action. Pharmacol Toxicol. 1991;69(3):149–156. https://doi.org/10.1111/j.1600-0773.1991.tb01289.x..
DOI: 10.1111/j.1600-0773.1991.tb01289.x
Goldberg H.L., Finnerty R.J. The Comparative Efficacy of Buspirone and Diazepam in the Treatment of Anxiety. Am J Psychiatry. 1979;136(9):1184–1187. https://doi.org/10.1176/AJP.136.9.1184..
DOI: 10.1176/AJP.136.9.1184
Lader M., Scotto J.C. A Multicentre Double-Blind Comparison of Hydroxyzine, Buspirone and Placebo in Patients with Generalized Anxiety Disorder. Psychopharmacology (Berl). 1998;139(4):402–406. https://doi.org/10.1007/s002130050731..
DOI: 10.1007/s002130050731
Landen M., Eriksson E., Agren H., Fahlen T. Effect of buspirone on sexual dysfunction in depressed patients treated with selective serotonin reuptake inhibitors. J Сlin Psychopharmacol. 1999;19(3):268–271. https://doi.org/10.1097/00004714-199906000-00012..
DOI: 10.1097/00004714-199906000-00012